Fundraising FoxEscient Pharmaceuticals
San Diego, US · Founded 2017 · 10 known investors
Find your way into Escient Pharmaceuticals
Sign up to find every way you can get introduced to Escient Pharmaceuticals
- Your email: who you already know at Escient Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Escient Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Company developing molecules targeting a novel class of receptors for neuro-immuno-inflammatory diseases; acquired by Incyte in May 2024.
Founders & leadership
Escient Pharmaceuticals was founded in 2017 by Alain Baron.
Board
Investors · 10
How we know: 5AM Ventures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: Avego BioScience Capital's portfolio page · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
How we know: The Column Group's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$108.8M disclosed across 3 rounds · 2018–2022
▶$60MraisedNov 2022 · 22 investors · BiotechnologyRule 506(b)
- Peter HirthDirector
- Charles ZukerDirector
- Kathleen Sereda GlaubDirector
- Jason HaflerDirector
- Kevin RaidyDirector
- Aaron MishelExecutive Officer
- Joshua GrassExecutive Officer, Director
- JeenJoo KangDirector
- Andrew SchwabDirector
- Marcus BoehmExecutive Officer
- Offering amount
- $120M
- Amount sold
- $60M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.8MraisedSep 2020 · 18 investors · BiotechnologyRule 506(b)
- Marcus BoehmExecutive Officer
- Charles ZukerDirector
- Kevin RaidyDirector
- Kathleen GlaubDirector
- Alain BaronExecutive Officer, Director
- Andrew SchwabDirector
- JeenJoo KangDirector
- Jason HaflerDirector
- Peter HirthDirector
- Offering amount
- $77.5M
- Amount sold
- $38.8M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$10MraisedApr 2018 · 10 investors · BiotechnologyRule 506(b)
- JeenJoo KangDirector
- Robert TjianDirector
- Alain BaronExecutive Officer, Director
- Marcus BoehmExecutive Officer
- Andrew SchwabDirector
- Offering amount
- $40M
- Amount sold
- $10M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Escient Pharmaceuticals do?
- Company developing molecules targeting a novel class of receptors for neuro-immuno-inflammatory diseases; acquired by Incyte in May 2024.
- Who founded Escient Pharmaceuticals?
- Escient Pharmaceuticals was founded by Alain Baron in 2017.
- Who are Escient Pharmaceuticals's investors?
- Escient Pharmaceuticals's investors include 5AM Ventures, Avego BioScience Capital, New Enterprise Associates (NEA), OUP (Osage University Partners), Sanofi Ventures, The Column Group, Abingworth, ALTITUDE LIFE SCIENCE VENTURES and 2 more.
- How much funding has Escient Pharmaceuticals raised?
- Escient Pharmaceuticals has disclosed $108.8M raised across 3 rounds.
- Where is Escient Pharmaceuticals headquartered?
- Escient Pharmaceuticals is headquartered in San Diego, US.